Darius Moradpour
About
In The Last Decade
Darius Moradpour
259 papers receiving 15.0k citations
Hit Papers
Peers
Comparison fields: 5 of 137
- Hepatology 10.4k
- Epidemiology 7.4k
- Molecular Biology 3.6k
- Immunology 3.0k
- Infectious Diseases 2.4k
Countries citing papers authored by Darius Moradpour
This map shows the geographic impact of Darius Moradpour's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Darius Moradpour with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Darius Moradpour more than expected).
Fields of papers citing papers by Darius Moradpour
This network shows the impact of papers produced by Darius Moradpour. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Darius Moradpour. The network helps show where Darius Moradpour may publish in the future.
Co-authorship network of co-authors of Darius Moradpour
This figure shows the co-authorship network connecting the top 25 collaborators of Darius Moradpour. A scholar is included among the top collaborators of Darius Moradpour based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Darius Moradpour. Darius Moradpour is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 10 | |
| 2 | 11 | |
| 3 | 0 | |
| 4 | 55 | |
| 5 | 16 | |
| 6 | 4 | |
| 7 | 69 | |
| 8 | 23 | |
| 9 | [New hepatitis C treatments: pharmacological considerations and potential for drug interactions]. | 4 |
| 10 | GLUT3 is induced during epithelial-mesenchymal transition and promotes tumor cell proliferation in non-small cell lung cancer | 1 |
| 11 | 10 | |
| 12 | EASL Clinical Practice Guidelines: Wilson's disease | 18 |
| 13 | 129 | |
| 14 | the Swiss Hepatitis C Cohort Study Group | 2 |
| 15 | 1 | |
| 16 | 0 | |
| 17 | 2 | |
| 18 | 209 | |
| 19 | 137 | |
| 20 | 77 |
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.